Bluejay Diagnostics, Inc.
BJDX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $3 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$0 | $0 | $0 | $3 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | – | – |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | – | – | 19.6% | – |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | -3,618.5% | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | -3,733.1% | – |
| EPS Diluted | -42.08 | -72.62 | -73.22 | -29.67 |
| % Growth | 42.1% | 0.8% | -146.8% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |